APA

Cook J. J., Sitko G. R., Holahan M. A., Stranieri M. T., Glass J. D., Askew B. C., McIntyre C. J., Claremon D. A., Baldwin J. J., Hartman G. D., Gould R. J. & Lynch J. J. (19970612). Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. : The Journal of pharmacology and experimental therapeutics.

Chicago

Cook J J, Sitko G R, Holahan M A, Stranieri M T, Glass J D, Askew B C, McIntyre C J, Claremon D A, Baldwin J J, Hartman G D, Gould R J and Lynch J J. 19970612. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. : The Journal of pharmacology and experimental therapeutics.

Harvard

Cook J. J., Sitko G. R., Holahan M. A., Stranieri M. T., Glass J. D., Askew B. C., McIntyre C. J., Claremon D. A., Baldwin J. J., Hartman G. D., Gould R. J. and Lynch J. J. (19970612). Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. : The Journal of pharmacology and experimental therapeutics.

MLA

Cook J J, Sitko G R, Holahan M A, Stranieri M T, Glass J D, Askew B C, McIntyre C J, Claremon D A, Baldwin J J, Hartman G D, Gould R J and Lynch J J. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. : The Journal of pharmacology and experimental therapeutics. 19970612.